Martin Schroeder serves as Executive at Genesis Biopharma, Inc, where they oversee executive responsibilities. Since joining the company, Martin Schroeder has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 22, 2011 involved purchasing 1,000,000 shares valued at $0.
Martin Schroeder currently holds 1,000,000 shares of Genesis Biopharma, Inc (GNBP.OB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Martin Schroeder has been a net neutral trader of GNBP.OB stock. They have purchased $0 and sold $0 worth of shares.
Martin Schroeder's most recent insider trade was on Aug 22, 2011, when they purchased 1,000,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.13 |
| Discretionary |